Influencia del soporte nutricional precoz y la presencia de diabetes mellitus en pacientes con ictus agudo / Impact of early nutritional support and presence of diabetes mellitus in patients with acute stroke

INTRODUCCIÓN: en la literatura actual se describen datos contradictorios en relación con el soporte nutricional en los pacientes con ictus y el momento idóneo de comenzar el mismo. OBJETIVO: analizar el impacto de los parámetros y la intervención nutricional en la evolución clínica de los pacientes afectos de ictus. MATERIAL Y MÉTODOS: estudio observacional, retrospectivo y descriptivo de 43 pacientes con diagnóstico de ictus agudo. Se recogen los siguientes parámetros nutricionales: pliegue tricipital (PT), circunferencia del brazo (CB), circunferencia muscular del brazo (CMB), albúmina, prealbúmina, colesterol total, linfocitos, diabetes mellitus (DM), inicio de soporte nutricional, duración y tipo de suplemento, y abordaje digestivo. También se registra la afectación neurológica según la escala National Institute of Health Stroke Scale (NIHSS) tanto en el momento basal como en el momento del alta. Se identifican la mortalidad en el primer mes y el déficit neurológico al alta como factores de mal pronóstico y se relacionan con los parámetros nutricionales. RESULTADOS: edad de 67,2 ± 12,5 años; 53,5% de varones y 34,9% de mujeres. Presencia de DM: 34,88%. Media de parámetros nutricionales: PT: 18,7 ± 7,8 mm; CB: 30,2 ± 3 cm; CMB: 24,4 ± 3,1 cm; albúmina: 3,39 ± 0,3 g/dl; prealbúmina: 22,3 ± 6,9 mg/dl; colesterol total: 177,1 ± 46,4 mg/dl; linfocitos: 1742 ± 885/mm3. Se inició el soporte nutricional enteral a los 4,3 ± 5,8 días del evento agudo, siendo su duración de 17,8 ± 23,2 días. El 50% de los pacientes presentaban al alta un déficit neurológico grave. Se identificaron como marcadores de peor pronóstico los siguientes: un retraso en el inicio del soporte nutricional superior a 7 días y la presencia de DM. CONCLUSIONES: el inicio tardío del soporte nutricional se relacionó con un peor pronóstico clínico. La DM constituye un marcador de mal pronóstico en los pacientes con ictus

INTRODUCTION: the data in the medical literature are conflicting regarding the nutritional support of patients with stroke and the most appropriate time to start it. OBJECTIVE: to analyze the effect of a nutritional intervention and of nutritional parameters on the clinical evolution of patients with stroke. MATERIAL AND METHODS: this was an observational, retrospective study in 43 patients. The following baseline data were collected: tricipital skinfold (TS), mid-upper arm circumference (MUAC), muscular arm circumference (MAC), albumin, prealbumin, total cholesterol, lymphocytes, diabetes mellitus (DM), nutritional support onset, duration and type of supplementation, nutrition care plan, neurological dysfunction according to the National Institute of Health Stroke Scale (NIHSS) both at baseline and discharge, and mortality. Mortality within the first month and neurological deficit at discharge are identified as poor prognostic factors, and are related to nutritional parameters. RESULTS: age 67.2 ± 12.5 years; 53.5 % males and 34.9 % females. Presence of DM: 34.88 %. Nutritional parameters: TS: 18.7 ± 7.8 mm; MUAC: 30.2 ± 3 cm; MAC: 24.4 ± 3.1 cm; serum albumin 3.39 ± 0.3 g/dl; prealbumin: 22.3 ± 6.9 mg/dl; total cholesterol: 177.1 ± 46.4 mg/dL; lymphocytes: 1742 ± 885/mm3. Enteral nutritional support was started at 4.3 ± 5.8 days after the acute event, with a duration of 17.8 ± 23.2 days. Fifty percent of patients had severe neurological deficits at discharge. As markers of worse prognosis we identified a delay in the start of nutritional support of over 7 days, and the presence of DM. CONCLUSIONS: the late start of nutritional support was related to worse clinical prognosis. DM is a marker of poor prognosis in patients with stroke

Cost-effectiveness of the hospital nutrition screening tool CIPA.

INTRODUCTION: Hospital malnutrition is very common and worsens the clinical course of patients while increasing costs. Lacking clinical-economic studies on the implementation of nutrition screening encouraged the evaluation of the CIPA (Control of Food Intake, Protein, Anthropometry) tool. MATERIAL AND METHODS: An open, non-randomized, controlled clinical trial was conducted on patients admitted to internal medicine and general and digestive surgery wards, who were either assigned to a control (standard hospital clinical care) or to an intervention, CIPA-performing ward (412 and 411, respectively; n = 823). Length of stay, mortality, readmission, in-hospital complications, and quality of life were evaluated. Cost-effectiveness was analysed in terms of cost per quality-adjusted life years (QALYs). RESULTS: The mean length of stay was higher in the CIPA group, though not significantly (+ 0.95 days; p = 0.230). On the surgical ward, more patients from the control group moved to critical care units (p = 0.014); the other clinical variables did not vary. Quality of life at discharge was similar (p = 0.53), although slightly higher in the CIPA group at 3 months (p = 0.089). Patients under CIPA screening had a higher mean cost of € 691.6 and a mean QALY gain over a 3-month period of 0.0042. While the cost per QALY for the internal medicine patients was € 642 282, the results for surgical patients suggest that the screening tool is both less costly and more effective. CONCLUSIONS: The CIPA nutrition screening tool is likely to be cost-effective in surgical but not in internal medicine patients.

[Impact of early nutritional support and presence of diabetes mellitus in patients with acute stroke]. / Influencia del soporte nutricional precoz y la presencia de diabetes mellitus en pacientes con ictus agudo.

INTRODUCTION: Introduction: the data in the medical literature are conflicting regarding the nutritional support of patients with stroke and the most appropriate time to start it. Objective: to analyze the effect of a nutritional intervention and of nutritional parameters on the clinical evolution of patients with stroke. Material and methods: this was an observational, retrospective study in 43 patients. The following baseline data were collected: tricipital skinfold (TS), mid-upper arm circumference (MUAC), muscular arm circumference (MAC), albumin, prealbumin, total cholesterol, lymphocytes, diabetes mellitus (DM), nutritional support onset, duration and type of supplementation, nutrition care plan, neurological dysfunction according to the National Institute of Health Stroke Scale (NIHSS) both at baseline and discharge, and mortality. Mortality within the first month and neurological deficit at discharge are identified as poor prognostic factors, and are related to nutritional parameters. Results: age 67.2 ± 12.5 years; 53.5% males and 34.9% females. Presence of DM: 34.88%. Nutritional parameters: TS: 18.7 ± 7.8 mm; MUAC: 30.2 ± 3 cm; MAC: 24.4 ± 3.1 cm; serum albumin 3.39 ± 0.3 g/dl; prealbumin: 22.3 ± 6.9 mg/dl; total cholesterol: 177.1 ± 46.4 mg/dL; lymphocytes: 1742 ± 885/mm3. Enteral nutritional support was started at 4.3 ± 5.8 days after the acute event, with a duration of 17.8 ± 23.2 days. Fifty percent of patients had severe neurological deficits at discharge. As markers of worse prognosis we identified a delay in the start of nutritional support of over 7 days, and the presence of DM. Conclusions: the late start of nutritional support was related to worse clinical prognosis. DM is a marker of poor prognosis in patients with stroke.

INTRODUCCIÓN: Introducción: en la literatura actual se describen datos contradictorios en relación con el soporte nutricional en los pacientes con ictus y el momento idóneo de comenzar el mismo. Objetivo: analizar el impacto de los parámetros y la intervención nutricional en la evolución clínica de los pacientes afectos de ictus. Material y métodos: estudio observacional, retrospectivo y descriptivo de 43 pacientes con diagnóstico de ictus agudo. Se recogen los siguientes parámetros nutricionales: pliegue tricipital (PT), circunferencia del brazo (CB), circunferencia muscular del brazo (CMB), albúmina, prealbúmina, colesterol total, linfocitos, diabetes mellitus (DM), inicio de soporte nutricional, duración y tipo de suplemento, y abordaje digestivo. También se registra la afectación neurológica según la escala National Institute of Health Stroke Scale (NIHSS) tanto en el momento basal como en el momento del alta. Se identifican la mortalidad en el primer mes y el déficit neurológico al alta como factores de mal pronóstico y se relacionan con los parámetros nutricionales. Resultados: edad de 67,2 ± 12,5 años; 53,5% de varones y 34,9% de mujeres. Presencia de DM: 34,88%. Media de parámetros nutricionales: PT: 18,7 ± 7,8 mm; CB: 30,2 ± 3 cm; CMB: 24,4 ± 3,1 cm; albúmina: 3,39 ± 0,3 g/dl; prealbúmina: 22,3 ± 6,9 mg/dl; colesterol total: 177,1 ± 46,4 mg/dl; linfocitos: 1742 ± 885/mm3. Se inició el soporte nutricional enteral a los 4,3 ± 5,8 días del evento agudo, siendo su duración de 17,8 ± 23,2 días. El 50% de los pacientes presentaban al alta un déficit neurológico grave. Se identificaron como marcadores de peor pronóstico los siguientes: un retraso en el inicio del soporte nutricional superior a 7 días y la presencia de DM. Conclusiones: el inicio tardío del soporte nutricional se relacionó con un peor pronóstico clínico. La DM constituye un marcador de mal pronóstico en los pacientes con ictus.

Comparison of Clinical Outcomes in Surgical Patients Subjected to CIPA Nutrition Screening and Treatment versus Standard Care.

Malnutrition is prevalent in surgical patients and leads to comorbidities and a poorer postoperative course. There are no studies that compare the clinical outcomes of implementing a nutrition screening tool in surgical patients with standard clinical practice. An open, non-randomized, controlled study was conducted in general and digestive surgical hospitalized patients, who were either assigned to standard clinical care or to nutrition screening using the Control of Food Intake, Protein, and Anthropometry (CIPA) tool and an associated treatment protocol (n = 210 and 202, respectively). Length of stay, mortality, readmissions, in-hospital complications, transfers to critical care units, and reinterventions were evaluated. Patients in the CIPA group had a higher Charlson index on admission and underwent more oncological and hepatobiliary-pancreatic surgeries. Although not significant, a shorter mean length of stay was observed in the CIPA group (-1.48 days; p < 0.246). There were also fewer cases of exitus (seven vs. one) and fewer transfers to critical care units in this group (p = 0.068 for both). No differences were detected in other clinical variables. In conclusion, patients subjected to CIPA nutrition screening and treatment showed better clinical outcomes than those receiving usual clinical care. The results were not statistically significant, possibly due to the heterogeneity across patient groups.

Eficacia en la remisión de la diabetes mellitus tipo 2 en pacientes sometidos a cirugía bariátrica en nuestro medio / Efficacy in type 2 diabetes mellitus remission in patients undergoing bariatric surgery

Objetivos: Evaluar la remisión de la diabetes mellitus tipo 2 (DM-2) tras cirugía bariátrica; analizar potenciales factores condicionantes y comparar criterios de remisión nacionales y americanos. Material y métodos: Estudio retrospectivo de pacientes diabéticos sometidos a bypass gástrico en Y de Roux entre 2009-2015. Variables recogidas: edad, sexo, años de evolución de DM-2, antidiabéticos, insulina (tipo y dosis), peso e IMC, porcentaje de sobrepeso perdido, HbA1c, glucemia y evolución de la DM-2 tras cirugía según criterios nacionales y americanos. Análisis descriptivo y correlación entre ambos consensos. Resultados: Se incluyeron 106 pacientes. Al año de la intervención (criterios nacionales): remisión completa 65,9%, remisión parcial 5,5%, mejoría 18,9% y sin cambios 9,7% (a los 5 años: 68,4; 5,3; 10,5 y 15,8%, respectivamente). Según criterios ADA: remisión completa 61,5%, remisión parcial 5,3% y sin remisión 28,6% (a los 5 años, remisión completa 68,4%). Buena correlación entre ambas clasificaciones (Rho=0,974; p<0,001). HbA1c media inicial: 7,3±1,8%; al año: 5,7±1%; a 5 años: 6,3±1,2%. Resultaron marcadores de peor probabilidad de remisión: edad superior a 50 años (54,4 vs. 88,2%; p=0,001), DM-2 de más de 10 años (26,3 vs. 81,8%; p<0,001), tratamiento con insulina (31,3 vs. 87,9%; p<0,001) y HbA1c≥8% (40 vs. 77%; p=0,001). Conclusiones: En nuestro centro, la cirugía bariátrica se asocia a una elevada tasa de remisión de DM-2 en pacientes con obesidad mórbida intervenidos, existiendo una buena correlación entre los criterios nacionales y los americanos. La edad superior a 50 años, una larga evolución de la DM-2, un peor control metabólico inicial y el tratamiento previo con insulina son marcadores de peor respuesta

Objectives: To assess remission of type 2 diabetes mellitus (T2DM) after bariatric surgery, to analyze potential conditioning factors, and to compare Spanish and American remission criteria. Material and methods: A retrospective study of diabetic patients undergoing Roux-en-Y gastric bypass from 2009 to 2015. Data collected included age, sex, time since T2DM diagnosis, antidiabetic drugs, insulin (type and dose), weight and BMI, percent excess weight lost, HbA1c, blood glucose levels, and course of T2DM after surgery according to Spanish and American criteria, including a descriptive analysis and correlation between both. Results: The study sample consisted of 106 patients. Outcomes one year after surgery was as follows (Spanish criteria): complete remission 65.9%, partial remission 5.5%, improvement 18.9%, no change 9.7% (at 5 years: 68.4, 5.3, 10.5, and 15.8%, respectively). Outcomes according to ADA criteria were as follows: complete remission 61.5%, partial remission 5.3%, and no remission 28.6% (after 5 years, complete remission 68.4%). There was a good correlation between both classifications (Rho=0.974; P<.001). Mean HbA1c levels: 7.3±1.8% at baseline; 5.7±1% at one year; 6.3±1.2% at 5 years. Chance of remission was lower in patients aged over 50 years (54.4 vs. 88.2%; P=.001), with T2DM diagnosed more than 10 years before (26.3 vs. 81.8%; P<.001), on insulin treatment (31.3 vs. 87.9%; P<.001), and with HbA1c levels≥8% (40 vs. 77%; P=.001). Conclusions: At our hospital, bariatric surgery is associated to a high remission rate of T2DM in patients with morbid obesity, with a good correlation between Spanish and American criteria. Age over 50 years old, long T2DM duration, poorer baseline metabolic control, and previous insulin treatment are markers of poorer response

Efficacy in type 2 diabetes mellitus remission in patients undergoing bariatric surgery. / Eficacia en la remisión de la diabetes mellitus tipo 2 en pacientes sometidos a cirugía bariátrica en nuestro medio.

OBJECTIVES: To assess remission of type 2 diabetes mellitus (T2DM) after bariatric surgery, to analyze potential conditioning factors, and to compare Spanish and American remission criteria. MATERIAL AND METHODS: A retrospective study of diabetic patients undergoing Roux-en-Y gastric bypass from 2009 to 2015. Data collected included age, sex, time since T2DM diagnosis, antidiabetic drugs, insulin (type and dose), weight and BMI, percent excess weight lost, HbA1c, blood glucose levels, and course of T2DM after surgery according to Spanish and American criteria, including a descriptive analysis and correlation between both. RESULTS: The study sample consisted of 106 patients. Outcomes one year after surgery was as follows (Spanish criteria): complete remission 65.9%, partial remission 5.5%, improvement 18.9%, no change 9.7% (at 5 years: 68.4, 5.3, 10.5, and 15.8%, respectively). Outcomes according to ADA criteria were as follows: complete remission 61.5%, partial remission 5.3%, and no remission 28.6% (after 5 years, complete remission 68.4%). There was a good correlation between both classifications (Rho=0.974; P<.001). Mean HbA1c levels: 7.3±1.8% at baseline; 5.7±1% at one year; 6.3±1.2% at 5 years. Chance of remission was lower in patients aged over 50 years (54.4 vs. 88.2%; P=.001), with T2DM diagnosed more than 10 years before (26.3 vs. 81.8%; P<.001), on insulin treatment (31.3 vs. 87.9%; P<.001), and with HbA1c levels≥8% (40 vs. 77%; P=.001). CONCLUSIONS: At our hospital, bariatric surgery is associated to a high remission rate of T2DM in patients with morbid obesity, with a good correlation between Spanish and American criteria. Age over 50 years old, long T2DM duration, poorer baseline metabolic control, and previous insulin treatment are markers of poorer response.

[Optimisation of nutritional screening tool CIPA: are two parameters of protein really necessary?] / Optimización del cribado nutricional CIPA: ¿son necesarios dos parámetros proteicos?

INTRODUCTION: the preliminary nutritional screening tool CIPA (food intake, proteins, anthropometry) is positive when it fulfills one of the following: control food intake (CI) 48-72 h < 50%, albumin < 3 g/dl, total protein < 5 g/dl, body mass index (BMI) < 18,5 kg/m2 or mid-upper arm circumference (MUAC) ≤ 22,5 cm. The use of two protein parameters increases costs and difficulty; one of them can be suppressed without affecting validity. OBJECTIVES: to evaluate the effectiveness of screening CIPA after exclusion of total protein. METHOD: prospective study of hospitalized patients; prevalence or risk of malnutrition was evaluated through CIPA and Subjective Global Assessment (SGA). Hospital malnutrition according to complete CIPA screening (with total proteins and albumin, [CIPAc] and without total proteins [CIPAw/p]) and concordance between both methods were analyzed, as well as the association of the positive screening result with clinical outcomes. RESULTS: three hundred and forty-three patients were analyzed. The prevalence or risk of malnutrition identified by complete CIPA (c) was 38.19% (33.02-43.36); by CIPA without protein (w/p), 37.32% (32.17-42.46); and SGA was 29.15% (24.32-33.99). Kappa index: 0.981 between both CIPAs, p < 0.001. Both CIPA and SGA detect patients with higher mortality in hospital and one month after discharge. Early readmission was higher in positive CIPA, statistical significantly in CIPAw/p (screening with positive results 21.88% vs screening with negative results 13.49%, p = 0.044), SGA 20.01% vs 15.23%, p = 0.28. Length of stay was higher in patients with positive screening in CIPAc, CIPAw/p and SGA. CONCLUSIONS: CIPAw/p is equally or more effective than the previously validated full CIPA; therefore, it could replace the latter saving costs. The prevalence of malnutrition is high in both variants and they are able to predict which patient has worse clinical prognosis.

Introducción: el cribado nutricional CIPA (control de ingestas, proteínas, antropometría) preliminar es positivo cuando se cumple uno de los siguientes parámetros: control de ingestas (CI) 48-72 h < 50%, albúmina < 3 g/dl, proteínas totales < 5 g/dl, índice de masa corporal (IMC) < 18,5 kg/m2 o circunferencia del brazo (CB) ≤ 22,5 cm (cuando el paciente no se puede pesar/tallar). El uso de dos parámetros proteicos aumenta costes y complejidad, pudiendo suprimirse uno de ellos sin afectar su validez.Objetivos: evaluar la efectividad del cribado CIPA tras exclusión de proteínas totales.Métodos: estudio prospectivo de pacientes hospitalizados valorando prevalencia o riesgo de desnutrición a través de CIPA y valoración global subjetiva (VGS). Análisis de desnutrición hospitalaria según el cribado CIPA completo (con proteínas totales y albúmina, CIPAc) y sin proteínas totales (CIPAs/p), y análisis de la concordancia entre ambos métodos. Estudio de la asociación del resultado positivo del cribado con factores pronósticos.Resultados: se analizaron 343 pacientes. Prevalencia de desnutrición: CIPAc 38,19% (33,02-43,36), CIPAs/p 37,32% (32,17-42,46), VGS 29,15% (24,32-33,99). Índice de correlación Kappa: 0,981 entre ambos CIPA, p < 0,001. Tanto las dos versiones de CIPA como la VGS detectan pacientes con mayor mortalidad hospitalaria y al mes del alta. Reingreso precoz: mayor en CIPA positivo, estadísticamente significativo en CIPAs/p (cribado positivo 21,88% vs. negativo 13,49%, p = 0,044), VGS 20,01% vs. 15,23%, p = 0,28. Estancia media: superior en pacientes con cribado positivo en las dos variantes de CIPA y en VGS.Conclusiones: CIPAs/p es igual o más eficaz que CIPAc validado previamente, por lo que puede sustituir a este último ahorrando costes. La prevalencia de desnutrición es elevada en ambas variantes y son capaces de identificar al paciente con peor pronóstico clínico.

Validity of the new nutrition screening tool Control of Food Intake, Protein, and Anthropometry (CIPA) in non-surgical inpatients.

INTRODUCTION: There is no gold-standard method for hospital nutrition screening. The new screening tool termed Control of Food Intake, Protein, and Anthropometry (CIPA) gives positive results when at least one of the following parameters is met: control of food intake for 72 h < 50%, serum albumin < 3 g/dl, body mass index < 18.5 kg/m2 or mid-upper arm circumference ≤ 22.5 cm. This method was validated in comparison with Subjective Global Assessment (SGA) in hospitalized patients with non-surgical pathologies. MATERIAL AND METHODS: A prospective, longitudinal study was performed on 221 consecutively enrolled patients. Prevalence or risk of malnutrition was estimated with CIPA vs. SGA screening at hospital admission and the concordance (k index - K) between the two methods and their sensitivity (S) and specificity (SP) were studied. Mean length of stay (LOS), mortality, and rate of early readmission were analyzed. RESULTS: The prevalence or risk of malnutrition identified by CIPA and SGA was 35.7% and 23.1%, respectively. K was 0.401 (p < 0.001); S and SP of CIPA vs. SGA were 72.5% and 75.3%, respectively. In contrast to SGA, CIPA-positive patients had an increased mean LOS compared to the negative ones (19.53 vs. 12.63 days, p < 0.001). Both methods detected a major risk of mortality in positive patients, but no difference in early readmission. CONCLUSIONS: The CIPA and the SGA screening tools detect patients with a higher risk of mortality, but only CIPA identifies patients with an increased mean LOS. CIPA screening proved valid for use in non-surgical inpatients.

Optimización del cribado nutricional cipa: ¿son necesarios dos parámetros proteicos? / Optimisation of nutritional screening tool CIPA: are two parameters of protein really necessary?

Introducción: el cribado nutricional CIPA (control de ingestas, proteínas, antropometría) preliminar es positivo cuando se cumple uno de los siguientes parámetros: control de ingestas (CI) 48-72 h < 50%, albúmina < 3 g/dl, proteínas totales < 5 g/dl, índice de masa corporal (IMC) < 18,5 kg/m2 o circunferencia del brazo (CB) ≤ 22,5 cm (cuando el paciente no se puede pesar/tallar). El uso de dos parámetros proteicos aumenta costes y complejidad, pudiendo suprimirse uno de ellos sin afectar su validez. Objetivos: evaluar la efectividad del cribado CIPA tras exclusión de proteínas totales. Métodos: estudio prospectivo de pacientes hospitalizados valorando prevalencia o riesgo de desnutrición a través de CIPA y valoración global subjetiva (VGS). Análisis de desnutrición hospitalaria según el cribado CIPA completo (con proteínas totales y albúmina, CIPAc) y sin proteínas totales (CIPAs/p), y análisis de la concordancia entre ambos métodos. Estudio de la asociación del resultado positivo del cribado con factores pronósticos. Resultados: se analizaron 343 pacientes. Prevalencia de desnutrición: CIPAc 38,19% (33,02-43,36), CIPAs/p 37,32% (32,17-42,46), VGS 29,15% (24,32-33,99). Índice de correlación Kappa: 0,981 entre ambos CIPA, p < 0,001. Tanto las dos versiones de CIPA como la VGS detectan pacientes con mayor mortalidad hospitalaria y al mes del alta. Reingreso precoz: mayor en CIPA positivo, estadísticamente significativo en CIPAs/p (cribado positivo 21,88% vs. negativo 13,49%, p = 0,044), VGS 20,01% vs. 15,23%, p = 0,28. Estancia media: superior en pacientes con cribado positivo en las dos variantes de CIPA y en VGS. Conclusiones: CIPAs/p es igual o más eficaz que CIPAc validado previamente, por lo que puede sustituir a este último ahorrando costes. La prevalencia de desnutrición es elevada en ambas variantes y son capaces de identificar al paciente con peor pronóstico clínico

Introduction: the preliminary nutritional screening tool CIPA (food intake, proteins, anthropometry) is positive when it fulfills one of the following: control food intake (CI) 48-72 h < 50%, albumin < 3 g/dl, total protein < 5 g/dl, body mass index (BMI) < 18,5 kg/m2 or mid-upper arm circumference (MUAC) ≤ 22,5 cm. The use of two protein parameters increases costs and difficulty; one of them can be suppressed without affecting validity. Objectives: to evaluate the effectiveness of screening CIPA after exclusion of total protein. Method: prospective study of hospitalized patients; prevalence or risk of malnutrition was evaluated through CIPA and Subjective Global Assessment (SGA). Hospital malnutrition according to complete CIPA screening (with total proteins and albumin, [CIPAc] and without total proteins [CIPAw/p]) and concordance between both methods were analyzed, as well as the association of the positive screening result with clinical outcomes. Results: three hundred and forty-three patients were analyzed. The prevalence or risk of malnutrition identified by complete CIPA (c) was 38.19% (33.02-43.36); by CIPA without protein (w/p), 37.32% (32.17-42.46); and SGA was 29.15% (24.32-33.99). Kappa index: 0.981 between both CIPAs, p < 0.001. Both CIPA and SGA detect patients with higher mortality in hospital and one month after discharge. Early readmission was higher in positive CIPA, statistical significantly in CIPAw/p (screening with positive results 21.88% vs screening with negative results 13.49%, p = 0.044), SGA 20.01% vs 15.23%, p = 0.28. Length of stay was higher in patients with positive screening in CIPAc, CIPAw/p and SGA. Conclusions: CIPAw/p is equally or more effective than the previously validated full CIPA; therefore, it could replace the latter saving costs. The prevalence of malnutrition is high in both variants and they are able to predict which patient has worse clinical prognosis

Clinical and cost-effectiveness analysis of early detection of patients at nutrition risk during their hospital stay through the new screening method CIPA: a study protocol.

BACKGROUND: Malnutrition is highly prevalent in hospitalized patients and results in a worsened clinical course as well as an increased length of stay, mortality, and costs. Therefore, simple nutrition screening systems, such as CIPA (control of food intake, protein, anthropometry), may be implemented to facilitate the patient's recovery process. The aim of this study is to evaluate the effectiveness and cost-effectiveness of implementing such screening tool in a tertiary hospital, consistent with the lack of similar, published studies on any hospital nutrition screening system. METHODS: The present study is carried out as an open, controlled, randomized study on patients that were admitted to the Internal Medicine and the General and Digestive Surgery ward; the patients were randomized to either a control or an intervention group (n = 824, thereof 412 patients in each of the two study arms). The control group underwent usual inpatient clinical care, while the intervention group was evaluated with the CIPA screening tool for early detection of malnutrition and treated accordingly. CIPA nutrition screening was performed upon hospital admission and classified positive when at least one of the following parameters was met: 72 h food intake control < 50%, serum albumin < 3 g/dL, body mass index < 18.5 kg/m2 (or mid-upper arm circumference ≤ 22.5 cm). In this case, the doctor decided on whether or not providing nutrition support. The following variables will be evaluated: hospital length of stay (primary endpoint), mortality, 3-month readmission, and in-hospital complications. Likewise, the quality of life questionnaires EQ-5D-5 L are being collected for all patients at hospital admission, discharge, and 3 months post-discharge. Analysis of cost-effectiveness will be performed by measuring effectiveness in terms of quality-adjusted life years (QALYs). The cost per patient will be established by identifying health care resource utilization; cost-effectiveness will be determined through the incremental cost-effectiveness ratio (ICER). We will calculate the incremental cost per QALY gained with respect to the intervention. DISCUSSION: This ongoing trial aims to evaluate the cost-effectiveness of implementing the malnutrition screening tool CIPA in a tertiary hospital. TRIAL REGISTRATION: Clinical Trial.gov ( NCT02721706 ). First receivevd: March 1, 2016 Last updated: April 8, 2017 Last verified: April 2017.

Análisis del grado de satisfacción alimentaria percibido por los pacientes en un hospital de tercer nivel.

Introducción: la alimentación constituye el pilar fundamental del soporte nutricional de los pacientes hospitalizados. Evaluar el grado de aceptación de la dieta es imprescindible en aras de combatir la desnutrición hospitalaria.Objetivos: a) determinar el grado de satisfacción de los pacientes en relación con las dietas; y b) analizar posibles variables asociadas a un grado de satisfacción mayor (apetito y tipo de dieta).Material y métodos: estudio descriptivo de corte transversal. Se emplea una encuesta de 17 preguntas con datos sociodemográficos, datos cualitativos, así como la valoración general del paciente. Se comparó el grado de satisfacción global en función del apetito y el tipo de dieta (terapéutica vs.basal; con sal vs.sosa) (Test no paramétric o Krustal-Wallis y T-Student para muestras independientes, respectivamente).Resultados: mil cuatrocientos trece pacientes. Edad: 53,9 ± 19 años; 51,3% mujeres. Dieta terapéutica (34,9%). Solo el 39,4% tomó dieta con sal. El 66,8% refirió ingresos previos. La alimentación del hospital para un 43% de pacientes fue ''como esperaba'', mientras que para un 44,1% fue ''mejor de lo que esperaba''. El horario de comidas era adecuado (89,1%) y el tiempo para comer, suficiente (96,4%). En cuanto a las características de la comida servida, consideraron como buenas o muy buenas la misma el porcentaje reflejado: sabor/gusto (56.3%), olor (65,5%), cocinado (69,2%), presentación (80,4%), tamaño de ración (75,9%), calidad (73%), cantidad (77,9%), variedad (67,6%), temperatura (70,4%). La valoración global de la alimentación en una escala de 1 a 10 fue de 6,8 ± 2,3. El apetito se asoció a un aumento significativo de la satisfacción global alimentaria del paciente (p < 0,01). El tipo de dieta o la presencia de sal en la misma no se asociaron a un aumento significativo de la satisfacción con la dieta de los pacientes (p = 0,99 y 0,35, respectivamente).Conclusiones: aunque el grado de satisfacción de la dieta de nuestro hospital es aceptable, es preciso introducir mejoras que aumenten su aceptación. El apetito se asocia a un aumento significativo de la satisfacción global alimentaria. La presencia de sal y el tipo de dieta (basal versusterapéutica) no se relacionan con una mejoría significativa de la valoración global de la dieta.

Análisis del grado de satisfacción alimentaria percibido por los pacientes en un hospital de tercer nivel / Assessment of the level of alimentary satisfaction received by patients in a tertiary hospital

Introducción: la alimentación constituye el pilar fundamental del soporte nutricional de los pacientes hospitalizados. Evaluar el grado de aceptación de la dieta es imprescindible en aras de combatir la desnutrición hospitalaria. Objetivos: a) determinar el grado de satisfacción de los pacientes en relación con las dietas; y b) analizar posibles variables asociadas a un grado de satisfacción mayor (apetito y tipo de dieta). Material y métodos: estudio descriptivo de corte transversal. Se emplea una encuesta de 17 preguntas con datos sociodemográficos, datos cualitativos, así como la valoración general del paciente. Se comparó el grado de satisfacción global en función del apetito y el tipo de dieta (terapéutica vs. basal; con sal vs. sosa) (Test no paramétric o Krustal-Wallis y T-Student para muestras independientes, respectivamente). Resultados: mil cuatrocientos trece pacientes. Edad: 53,9 ± 19 años; 51,3% mujeres. Dieta terapéutica (34,9%). Solo el 39,4% tomó dieta con sal. El 66,8% refi rió ingresos previos. La alimentación del hospital para un 43% de pacientes fue «como esperaba», mientras que para un 44,1% fue «mejor de lo que esperaba». El horario de comidas era adecuado (89,1%) y el tiempo para comer, suficiente (96,4%). En cuanto a las características de la comida servida, consideraron como buenas o muy buenas la misma el porcentaje reflejado: sabor/gusto (56.3%), olor (65,5%), cocinado (69,2%), presentación (80,4%), tamaño de ración (75,9%), calidad (73%), cantidad (77,9%), variedad (67,6%), temperatura (70,4%). La valoración global de la alimentación en una escala de 1 a 10 fue de 6,8 ± 2,3. El apetito se asoció a un aumento significativo de la satisfacción global alimentaria del paciente (p < 0,01). El tipo de dieta o la presencia de sal en la misma no se asociaron a un aumento significativo de la satisfacción con la dieta de los pacientes (p = 0,99 y 0,35, respectivamente). Conclusiones: aunque el grado de satisfacción de la dieta de nuestro hospital es aceptable, es preciso introducir mejoras que aumenten su aceptación. El apetito se asocia a un aumento significativo de la satisfacción global alimentaria. La presencia de sal y el tipo de dieta (basal versus terapéutica) no se relacionan con una mejoría significativa de la valoración global de la dieta (AU)

Introduction: Food is a key element of nutritional support of hospitalized patients. To assess the level of food acceptance is essential to fight hospitalary malnutrition. Aims: a) To determine the level of satisfaction of patients to our diets; and b) to analyse variables associated with a higher level of satisfaction (appetite and type of diet). Material and methods: Cross-sectional descriptive study. A survey was used, including socio-demographic data, qualitative data as well as the overall assessment of the patient. The global level of satisfaction was compared depending on the appetite and on the type of diet (therapeutic versus basal; with salt versus unsalted) (non-parametric Krustal-Wallis test and T-students for independent samples, respectively). Results: One thousand four hundred and thirteen patients. Age: 53.9 ± 19 year old; 51.3% women. Therapeutic diet (34.9%). Only 39.4% took a salted diet. The 66.8% confirmed previous admissions. Food hospital for 43% of patients was «as expected», while for 44.1% «better than it was expected». Meal times were adequate for 89.1% and the time for eating enough in 96.4%. About the food served, the percentage of patients who considered as good or very good: taste (56.3%), smell (65.5%), cooked (69.2%), variety (67.6%), temperature (70.4%). The global assessment of food on scale 1 to 10 was 6.8 ± 2.3. The appetite was associated with a significant increase in global food patient satisfaction (p < 0.01). The type of diet or the presence of salt were not related to a relevant increase of satisfaction with the patient’s diet (p = 0.99 y 0.35, respectively). Conclusions: Although the level of satisfaction of our hospital diet is reasonable, we should introduce improvements which enhance its acceptance. Appetite is associated with a significant increase in global food satisfaction. The presence of salt or the type of diet (basal versus therapeutic) is not related to an outstanding improvement of the overall assessment of the diet (AU)

Relationship between Mid-Upper Arm Circumference and Body Mass Index in Inpatients.

INTRODUCTION: Nutritional screening is a fundamental aspect of the initial evaluation of the hospitalised patient. Body Mass Index (BMI) in association with other parameters is a good marker of malnutrition (<18.5 kg/m2), but it presents the handicap that the great majority of patients cannot be weighed and measured. For this reason it is necessary to find other indicators that can be measured in these patients. OBJECTIVES: 1) Analyse the relationship between BMI and Mid-Upper Arm Circumference (MUAC); 2) establish a cut-off point of MUAC equivalent to BMI <18.5 kg/m2. MATERIALS AND METHODS: The anthropometric data of patients hospitalised over the period 2004-2013 were retrospectively revised. The following variables were collected: weight, height, BMI, MUAC, sex and age. RESULTS: 1373 patients were evaluated, who presented a mean weight of: 65.04±15.51 kg; height: 1.66±0.09 m; BMI: 23.48±5.03 kg/m2; MUAC: 26.95±4.50 cm; age: 56.24±16.77. MUAC correlates suitably to BMI by means of the following equation (simple linear regression): BMI = - 0.042 + 0.873 x MUAC (cm) (R2 = 0.609), with a Pearson r value of 0.78 (p<0.001). The area under the curve of MUAC for the diagnosis of malnutrition was 0.92 (95% CI: 0.90-0.94; p<0.001). The MUAC value ≤22.5 cm presented a sensitivity of 67.7%, specificity of 94.5%, and a correct classification of 90%. No significant statistical differences were found in the cut-off point of MUAC for the diagnosis of malnutrition based on sex (p = 0.115) and age (p = 0.694). CONCLUSIONS: 1) MUAC correlates positively and significantly with BMI. 2) MUAC ≤ 22.5 cm correlates properly with a BMI of <18.5 kg/m2, independent of the age or sex of the patient, although there are other alternatives. MUAC constitutes a useful tool as a marker of malnutrition, fundamentally in patients for whom weight and height cannot be determined.

[CONCORDANCE IN THE RESULTS OF CONTROL INTAKE PERFORMANCE OF 72 H BY DIFFERENT HEALTH PROFESSIONALS IN A TERTIARY HOSPITAL]. / CONCORDANCIA EN LOS RESULTADOS TRAS LA REALIZACIÓN DE UN CONTROL DE INGESTAS DE 72 H POR DIFERENTE PERSONAL SANITARIO EN UN HOSPITAL DE TERCER NIVEL.

INTRODUCTION: the nutritional screening CIPA is positive when it fulfills one of the following parameters: Control food Intake (CI) 72 h < 50%; albumin < 3 g/dl; Body Mass Index (BMI) < 18,5 kg/m2 or Mid-Upper Arm Circumference (MUAC) ≤ 22,5 cm (if BMI cannot be determined). The only parameter no totally objective is the CI so that this study seeks to reinforce its validity. OBJECTIVES: analyze the existing concordance among different health professionals when assessing a CI of 72 h. MATERIALS AND METHOD: retrospective study of patients admitted in hospitalization wards (February-October 2014). Variables considered: age, sex, health service, CI of 72 h and type of diet. The aim of CI is to assess the amount of food consumed, differing between superior or inferior intakes to 50%. It is analyzed the concordance of the results CI determined by a doctor, a nurse and a nutritionist (gold-standard) by the coefficient Kappa (K). Subsequently the sensitivity (S) and specificity (Sp) of positive CI were computed. RESULTS: 176 control of food intake were analyzed. Age 63.70 } 14.46 years; 42% women. Units: Digestive (22.2%), Pneumology (42%), Internal Medicine (21.6%), Nephrology (9.1%), others (5.1%). Type of diet: basal (23%), therapeutic (67%), consistency (4%), progressive (3.4%), others (2.3%). It was compared the nursing CI vs. nutritionist (K = 0.798; p < 0.001), and the doctor vs. nutritionist (K = 0.823; p < 0.001). The S and Sp of nursing vs. nutritionist was 84% and 97% while between the doctor and the nutritionist was 84% and 98% respectively. CONCLUSIONS: the concordance of the results of a CI of 72 hours (intakes < or > to 50%) performed in patients hospitalized by a doctor, nurse, and nutritionist is high, minimizing subjectivity to this parameter. The CI is helpful for its use within the routine clinical practice, and particularly within the nutritional screenings, such as CIPA.

Introducción: el cribado nutricional CIPA es positivo cuando se cumple uno de los siguientes parametros: Control de Ingestas (CI) 72 h < 50%; albumina < 3 g/dl; Indice de Masa Corporal (IMC) < 18,5 kg/m2 o Circunferencia del Brazo (CB) ≤ 22,5 cm (si no se puede determinar IMC). El unico parametro no totalmente objetivo es el CI, por lo que este estudio busca reforzar la validez del mismo. Objetivos: analizar la concordancia existente entre diferentes profesionales sanitarios a la hora de evaluar un CI de 72 h. Material y métodos: estudio prospectivo de pacientes ingresados en plantas de hospitalizacion (febrero-octubre de 2014). Variables recogidas: edad, sexo, servicio medico, CI de 72 h y tipo de dieta. El objetivo del CI es valorar la cantidad de alimento consumido, diferenciando entre ingestas superiores o inferiores al 50%. Se analiza la concordancia de los resultados del CI dictaminados por un medico, una enfermera y un nutricionista (gold-standar) mediante el coeficiente Kappa (K). Posteriormente se calculo la sensibilidad (S) y la especificidad (E) de los CI positivos. Resultados: se analizaron 176 controles de ingestas. Edad: 63,70 } 14,46 anos; 42% mujeres. Servicios: Digestivo (22,2%), Neumologia (42%), Medicina Interna (21,6%), Nefrologia (9,1%), Otros (5,1%). Tipo de dieta: basal (23,3%), terapeutica (67%), consistencia (4%), progresion (3,4%), otros (2,3%). Se comparo el CI de enfermeria vs. nutricionista (K = 0,798; p < 0,001), y del medico vs. nutricionista (K = 0,823; p < 0,001). La S y E de enfermeria vs. nutricionista fue de 84% y 97%, mientras que entre medico y nutricionista fue de 84% y 98%, respectivamente. Conclusiones: la concordancia de los resultados de un CI de 72 horas (ingestas < o > al 50%) realizado en pacientes hospitalizados por un medico, una enfermera y un nutricionista es alta, restando subjetividad a este parametro. El CI resulta util para su uso dentro de la practica clinica habitual y, en concreto, dentro de cribados nutricionales, como el CIPA.

Concordancia en los resultados tras la realización de un control de ingestas de 72 h por diferente personal sanitario en un hospital de tercer nivel / Concordance in the results of control intake performance of 72 h by different health professionals in a tertiary hospital

Introducción: el cribado nutricional CIPA es positivo cuando se cumple uno de los siguientes parámetros: Control de Ingestas (CI) 72 h <50%; albúmina <3 g/dl; Índice de Masa Corporal (IMC) <18,5 kg/m2 o Circunferencia del Brazo (CB) ≤22,5 cm (si no se puede determinar IMC). El único parámetro no totalmente objetivo es el CI, por lo que este estudio busca reforzar la validez del mismo. Objetivos: analizar la concordancia existente entre diferentes profesionales sanitarios a la hora de evaluar un CI de 72 h. Material y métodos: estudio prospectivo de pacientes ingresados en plantas de hospitalización (febrero-octubre de 2014). Variables recogidas: edad, sexo, servicio médico, CI de 72 h y tipo de dieta. El objetivo del CI es valorar la cantidad de alimento consumido, diferenciando entre ingestas superiores o inferiores al 50%. Se analiza la concordancia de los resultados del CI dictaminados por un médico, una enfermera y un nutricionista (gold-standar) mediante el coeficiente Kappa (K). Posteriormente se calculó la sensibilidad (S) y la especificidad (E) de los CI positivos. Resultados: se analizaron 176 controles de ingestas. Edad: 63,70±14,46 años; 42% mujeres. Servicios: Digestivo (22,2%), Neumología (42%), Medicina Interna (21,6%), Nefrología (9,1%), Otros (5,1%). Tipo de dieta: basal (23,3%), terapéutica (67%), consistencia (4%), progresión (3,4%), otros (2,3%). Se comparó el CI de enfermería vs. nutricionista (K=0,798; p<0,001), y del médico vs. nutricionista (K=0,823; p<0,001). La S y E de enfermería vs. nutricionista fue de 84% y 97%, mientras que entre médico y nutricionista fue de 84% y 98%, respectivamente. Conclusiones: la concordancia de los resultados de un CI de 72 horas (ingestas < o > al 50%) realizado en pacientes hospitalizados por un médico, una enfermera y un nutricionista es alta, restando subjetividad a este parámetro. El CI resulta útil para su uso dentro de la práctica clínica habitual y, en concreto, dentro de cribados nutricionales, como el CIPA (AU)

Introduction: the nutritional screening CIPA is positive when it fulfills one of the following parameters: Control food Intake (CI) 72 h <50%; albumin <3 g/dl; Body Mass Index (BMI) <18,5 kg/m2 or Mid-Upper Arm Circumference (MUAC) <=22,5 cm (if BMI cannot be determined). The only parameter no totally objective is the CI so that this study seeks to reinforce its validity. Objectives: analyze the existing concordance among different health professionals when assessing a CI of 72 h. Materials and method: retrospective study of patients admitted in hospitalization wards (February-October 2014). Variables considered: age, sex, health service, CI of 72 h and type of diet. The aim of CI is to assess the amount of food consumed, differing between superior or inferior intakes to 50%. It is analyzed the concordance of the results CI determined by a doctor, a nurse and a nutritionist (gold-standard) by the coefficient Kappa (K). Subsequently the sensitivity (S) and specificity (Sp) of positive CI were computed. Results: 176 control of food intake were analyzed. Age 63.70±14.46 years; 42% women. Units: Digestive (22.2%), Pneumology (42%), Internal Medicine (21.6%), Nephrology (9.1%), others (5.1%). Type of diet: basal (23%), therapeutic (67%), consistency (4%), progressive (3.4%), others (2.3%). It was compared the nursing CI vs. nutritionist (K=0.798; p<0.001), and the doctor vs. nutritionist (K=0.823; p<0.001). The S and Sp of nursing vs. nutritionist was 84% and 97% while between the doctor and the nutritionist was 84% and 98% respectively. Conclusions: the concordance of the results of a CI of 72 hours (intakes < or > to 50%) performed in patients hospitalized by a doctor, nurse, and nutritionist is high, minimizing subjectivity to this parameter. The CI is helpful for its use within the routine clinical practice, and particularly within the nutritional screenings, such as CIPA (AU)

[Introducing a mixed nutritional screening tool (CIPA) in a tertiary hospital]. / Introducción de un método mixto de cribado nutricional (CIPA) en un hospital de tercer nivel.

INTRODUCTION: Malnourishment in hospitalized patients is very prevalent and therefore it is important to implement screening methods. A mixed nutritional screening method (CIPA) has been developed at our center; this method includes four parameters: (a) control of intakes for 72 h; (b) BMI; (c) proteins; and (d) albumin. OBJECTIVES: (1) To know the prevalence of malnourishment at the Internal Medicine Department of our Center; (2) To analyze the variables associated to higher prevalence of malnourishment. MATERIALS AND METHOD: The results of the nutritional screening tests carried out in 305 patients admitted to the Internal Medicine Department in the period of November of 2012-October of 2013 were retrospectively reviewed. The prevalence of hospital malnourishment was analyzed, as well as the association of a positive screening test (at least one positive item) with the following variables: BMI, age, gender, underlying disease, hospital staying, early re-admittance (< 1 month) and hospital mortality. RESULTS: The test yielded a positive result in 23% of the patients. Patients with a positive screening test had lower BMI (24.9 ± 7.2 vs. 27.8 ± 6.4 kg/m; p = 0.002). Neoplastic and infectious pathologies were associated with greater positivity (35.3 and 28.9%, respectively; p = 0.006). Gender and age were not associated with a positive screening test. Patients with a positive screening test had longer mean hospital staying (26.7 ± 25 vs. 19.4 ± 16.5; p = 0.005), higher early re-admittance rates (18.6 vs. 6.8%; p = 0.003) and higher mortality (30 vs. 10.3%; p < 0.001). CONCLUSIONS: The CIPA screening test can detect malnourished patients and predict worse clinical prognosis (mortality, mean hospital staying and early readmittance).

Introducción: La desnutrición en el paciente hospitalizado es muy prevalente, por lo que es importante incorporar métodos de depistaje. Se ha desarrollado en nuestro centro un método mixto de cribado nutricional (CIPA), que incluye cuatro parámetros: a) control de ingestas 72 h; b) IMC; c) proteínas; y d) albúmina. Objetivos: 1) conocer la prevalencia de desnutrición en pacientes hospitalizados en el servicio de Medicina Interna de nuestro centro; 2) analizar variables asociadas a mayor prevalencia de desnutrición; 3) evaluar su efecto pronóstico clínico. Material y métodos: Se revisaron retrospectivamente los resultados de los test de cribado nutricional efectuados a 305 pacientes ingresados en el servicio de Medicina Interna en el periodo noviembre/2012-octubre/2013. Se analizó la prevalencia de desnutrición hospitalaria y la asociación del resultado positivo en el cribado (al menos un ítem positivo) con las siguientes variables: IMC, edad, sexo, patología subyacente, estancia, reingreso precoz (< de 1 mes) y mortalidad. Resultados: El test fue positivo en un 23% de los pacientes. Los pacientes con cribado positivo presentaban un IMC inferior (24,9 ± 7,2 vs 27,8 ± 6,4 kg/m; p = 0,002). La patología neoplásica e infecciosa se asociaron a mayor positividad (35,3 y 28,9%, respectivamente; p=0,006). El sexo y la edad no se asociaron con el resultado del test de cribado. Los pacientes con cribado positivo presentaban mayor estancia media (26,7 ± 25 vs 19,4 ± 16,5; p = 0,005), tasa de reingresos precoces (18,6 vs 6,8%; p = 0,003) y mortalidad (30 vs 10,3%; p < 0,001). Conclusiones: El test de cribado CIPA es capaz de detectar al paciente malnutrido y predecirle un peor pronóstico clínico (mortalidad, estancia media y reingreso precoz).

Introducción de un método mixto de cribado nutricional (CIPA) en un hospital de tercer nivel / Introducing a mixed nutritional screening tool (CIPA) in a tertiary hospital

Introducción: La desnutrición en el paciente hospitalizado es muy prevalente, por lo que es importante incorporar métodos de depistaje. Se ha desarrollado en nuestro centro un método mixto de cribado nutricional (CIPA), que incluye cuatro parámetros: a) control de ingestas 72 h; b) IMC; c) proteínas; y d) albúmina. Objetivos: 1) conocer la prevalencia de desnutrición en pacientes hospitalizados en el servicio de Medicina Interna de nuestro centro; 2) analizar variables asociadas a mayor prevalencia de desnutrición; 3) evaluar su efecto pronóstico clínico. Material y métodos: Se revisaron retrospectivamente los resultados de los test de cribado nutricional efectuados a 305 pacientes ingresados en el servicio de Medicina Interna en el periodo noviembre/2012-octubre/2013. Se analizó la prevalencia de desnutrición hospitalaria y la asociación del resultado positivo en el cribado (al menos un ítem positivo) con las siguientes variables: IMC, edad, sexo, patología subyacente, estancia, reingreso precoz (< de 1 mes) y mortalidad. Resultados: El test fue positivo en un 23% de los pacientes. Los pacientes con cribado positivo presentaban un IMC inferior (24,9 ± 7,2 vs 27,8 ± 6,4 kg/m; p = 0,002). La patología neoplásica e infecciosa se asociaron a mayor positividad (35,3 y 28,9%, respectivamente; p=0,006). El sexo y la edad no se asociaron con el resultado del test de cribado. Los pacientes con cribado positivo presentaban mayor estancia media (26,7 ± 25 vs 19,4 ± 16,5; p = 0,005), tasa de reingresos precoces (18,6 vs 6,8%; p = 0,003) y mortalidad (30 vs 10,3%; p < 0,001). Conclusiones: El test de cribado CIPA es capaz de detectar al paciente malnutrido y predecirle un peor pronóstico clínico (mortalidad, estancia media y reingreso precoz) (AU)

Introduction: Malnourishment in hospitalized patients is very prevalent and therefore it is important to implement screening methods. A mixed nutritional screening method (CIPA) has been developed at our center; this method includes four parameters: a) control of intakes for 72 h; b) BMI; c) proteins; and d) albumin. Objectives: 1) To know the prevalence of malnourishment at the Internal Medicine Department of our Center; 2) To analyze the variables associated to higher prevalence of malnourishment. Materials and method: The results of the nutritional screening tests carried out in 305 patients admitted to the Internal Medicine Department in the period of November of 2012-October of 2013 were retrospectively reviewed. The prevalence of hospital malnourishment was analyzed, as well as the association of a positive screening test (at least one positive item) with the following variables: BMI, age, gender, underlying disease, hospital staying, early re-admittance (< 1 month) and hospital mortality. Results: The test yielded a positive result in 23% of the patients. Patients with a positive screening test had lower BMI (24.9 ± 7.2 vs. 27.8 ± 6.4 kg/m; p = 0.002). Neoplastic and infectious pathologies were associated with greater positivity (35.3 and 28.9%, respectively; p = 0.006). Gender and age were not associated with a positive screening test. Patients with a positive screening test had longer mean hospital staying (26.7 ± 25 vs. 19.4 ± 16.5; p = 0.005), higher early re-admittance rates (18.6 vs. 6.8%; p = 0.003) and higher mortality (30 vs. 10.3%; p < 0.001). Conclusions: The CIPA screening test can detect malnourished patients and predict worse clinical prognosis (mortality, mean hospital staying and early readmittance) (AU)

Validación de un método de dispensación de suplementos nutricionales en un hospital terciario / Validation of a method of dispensing nutritional supplements in a tertiary hospital

Introducción: Los suplementos nutricionales constituyen un pilar fundamental del tratamiento de la desnutrición hospitalaria, aunque su coste es elevado. Son precisos métodos que permitan una prescripción racional de los mismos. Objetivos: Analizar la validez de los criterios de dispensación de suplementos nutricionales (SN) utilizados en nuestro centro (empleando como referencia el sistema CONUT). Material y métodos: Se revisaron retrospectivamente los formularios de solicitud de SN remitidos por los distintos servicios durante 15 meses (abril/2010-junio/2011). Se analizaron las siguientes variables: servicio solicitante, patología, IMC, pérdida de peso reciente, disminución de la ingesta mayor del 50%, proteínas totales, albúmina, linfocitos, colesterol total y valoración del grado de desnutrición según sistema CONUT. Se comparó la validez de nuestros criterios de dispensación de SN con el sistema CONUT (empleando el coeficiente Kappa). Resultados: Se recibieron 524 solicitudes (34,9/mes). Patologías: infecciosa (31,1%), tumoral (26,1%), postquirúrgica (19%), otras (23,8%). Había pérdida de peso reciente en el 88,9% de los pacientes, y una disminución de la ingesta superior al 50% en el 83,4%. IMC: 24,8 ± 7,5 kg/m2. Parámetros analíticos: albúmina 2,6 ± 0,7 g/dl, proteínas totales 5,7 ± 2,4 g/dl, colesterol total 152 ± 172 mg/dl, linfocitos 1.561 ± 1.842/mm3. Valoración del grado de desnutrición según sistema CONUT: normal (12%), desnutrición leve (23,1%), moderada (41,6%), grave (23,3%). Cumplimiento de los requisitos de nuestro centro hospitalario para la dispensación de SN: ninguno (6,3%), uno (33,6%), dos (43,1%), los tres (17%). Se comparó el número de dichos requisitos con el grado de desnutrición (sistema CONUT), obteniéndose un índice de concordancia débil (Kappa = 0,207; p < 0,001). 156 pacientes (29,8% de las solicitudes) recibieron SN, a pesar de presentar grado de nutrición normal o desnutrición leve de acuerdo al sistema CONUT. La mayor parte de dichas solicitudes (116; 74,4%) cumplían un único requisito para la dispensación de SN, y en el 93,9% de las mismas el criterio alegado por el médico solicitante era la disminución de la ingesta mayor del 50%. Conclusiones: Nuestro método de dispensación de SN detecta un mayor porcentaje de pacientes susceptibles de suplementación nutricional que el sistema CONUT. La principal ventaja de nuestro sistema es la valoración de la disminución de la ingesta, que es la principal indicación de SN en el medio hospitalario (AU)

Introduction: Nutritional supplements are an essential component of the management of hospital hyponutrition, although their costs are high. There exists the need for methods allowing a rational prescription of them. Objectives: To analyze the validity of the criteria for dispensing the nutritional supplements (NS) used at our center (by using as a reference the CONUT system). Material and method: We retrospectively reviewed the petition formularies of NS sent from the different departments for 15 months (April/2010-June/2011). We analyzed the following variables: petitionary department; pathology; BMI; recent weight loss; decreased intake > 50%; total proteins; albumin; lymphocytes; total cholesterol; and assessment of the hyponutrition level according to the CONUT system. We compared the validity of our dispensing criteria of NS to those of the CONUT system by means of the Kappa coefficient. Results: We received 524 petitions (34.9/month). Pathologies: infectious (31.1%), tumor (26.1%), postsurgical (19%), others (23.8%). 88.9% of the patients had recent weight loss and 83.4% decreased intake > 50%. BMI: 24.8 ± 7.5 kg/m2. Laboratory parameters: albumin 2.6 ± 0.7 g/dL, total proteins 5.7 ± 2.4 g/dL, total cholesterol 152 ± 172 mg/dL, lymphocytes 1,561 ± 1,842/ mm3. Assessment of the hyponutrition level according to the CONUT system: normal (12%), mild hyponutrition (23.1%), moderate (41.6%), severe (23.3%). Adherence to our hospital requisites for the dispensation of NS: none (6.3%), one (33.6%), two (43.1%), all three (17%). We compared the number of requisites to the degree of hyponutrition (CONUT system), yielding a weak agreement index (Kappa = 0.207; p < 0.001). 156 patients (29.8% of all the petitions) received a NS in spite of having a normal nutrition level or mild hyponutrition according to the CONUT system. Most of these commands (116; 74.4%) met just one criterion for dispensing a NS, and in 93.9% of them the reason alleged by the physician was a decreased intake > 50%. Conclusions: our dispensation method of NS detects a greater percentage of patients susceptible of nutritional supplementation than the CONUT system. The main advantage of our system is the assessment of a decreased intake, which is the main indication for a NS at the hospital setting (AU)

[Validation of a method of dispensing nutritional supplements in a tertiary hospital]. / Validación de un método de dispensación de suplementos nutricionales en un hospital terciario.

INTRODUCTION: Nutritional supplements are an essential component of the management of hospital hyponutrition, although their costs are high. There exists the need for methods allowing a rational prescription of them. OBJECTIVES: To analyze the validity of the criteria for dispensing the nutritional supplements (NS) used at our center (by using as a reference the CONUT system). MATERIAL AND METHOD: We retrospectively reviewed the petition formularies of NS sent from the different departments for 15 months (April/2010-June/2011). We analyzed the following variables: petitionary department; pathology; BMI; recent weight loss; decreased intake > 50%; total proteins; albumin; lymphocytes; total cholesterol; and assessment of the hyponutrition level according to the CONUT system. We compared the validity of our dispensing criteria of NS to those of the CONUT system by means of the Kappa coefficient. RESULTS: We received 524 petitions (34.9/month). Pathologies: infectious (31.1%), tumor (26.1%), postsurgical (19%), others (23.8%). 88.9% of the patients had recent weight loss and 83.4% decreased intake > 50%. BMI: 24.8 ± 7.5 kg/m². Laboratory parameters: albumin 2.6 ± 0.7 g/dL, total proteins 5.7 ± 2.4 g/dL, total cholesterol 152 ± 172 mg/dL, lymphocytes 1,561 ± 1,842/ mm3. Assessment of the hyponutrition level according to the CONUT system: normal (12%), mild hyponutrition (23.1%), moderate (41.6%), severe (23.3%). Adherence to our hospital requisites for the dispensation of NS: none (6.3%), one (33.6%), two (43.1%), all three (17%). We compared the number of requisites to the degree of hyponutrition (CONUT system), yielding a weak agreement index (Kappa = 0.207; p < 0.001). 156 patients (29.8% of all the petitions) received a NS in spite of having a normal nutrition level or mild hyponutrition according to the CONUT system. Most of these commands (116; 74.4%) met just one criterion for dispensing a NS, and in 93.9% of them the reason alleged by the physician was a decreased intake > 50%. CONCLUSIONS: our dispensation method of NS detects a greater percentage of patients susceptible of nutritional supplementation than the CONUT system. The main advantage of our system is the assessment of a decreased intake, which is the main indication for a NS at the hospital setting.

Introducción: Los suplementos nutricionales constituyen un pilar fundamental del tratamiento de la desnutrición hospitalaria, aunque su coste es elevado. Son precisos métodos que permitan una prescripción racional de los mismos. Objetivos: Analizar la validez de los criterios de dispensación de suplementos nutricionales (SN) utilizados en nuestro centro (empleando como referencia el sistema CONUT). Material y métodos: Se revisaron retrospectivamente los formularios de solicitud de SN remitidos por los distintos servicios durante 15 meses (abril/2010-junio/2011). Se analizaron las siguientes variables: servicio solicitante, patología, IMC, pérdida de peso reciente, disminución de la ingesta mayor del 50%, proteínas totales, albúmina, linfocitos, colesterol total y valoración del grado de desnutrición según sistema CONUT. Se comparó la validez de nuestros criterios de dispensación de SN con el sistema CONUT (empleando el coeficiente Kappa). Resultados: Se recibieron 524 solicitudes (34,9/mes). Patologías: infecciosa (31,1%), tumoral (26,1%), postquirúrgica (19%), otras (23,8%). Había pérdida de peso reciente en el 88,9% de los pacientes, y una disminución de la ingesta superior al 50% en el 83,4%. IMC: 24,8 ± 7,5 kg/m2. Parámetros analíticos: albúmina 2,6 ± 0,7 g/dl, proteínas totales 5,7 ± 2,4 g/dl, colesterol total 152 ± 172 mg/dl, linfocitos 1.561 ± 1.842/mm3. Valoración del grado de desnutrición según sistema CONUT: normal (12%), desnutrición leve (23,1%), moderada (41,6%), grave (23,3%). Cumplimiento de los requisitos de nuestro centro hospitalario para la dispensación de SN: ninguno (6,3%), uno (33,6%), dos (43,1%), los tres (17%). Se comparó el número de dichos requisitos con el grado de desnutrición (sistema CONUT), obteniéndose un índice de concordancia débil (Kappa = 0,207; p < 0,001). 156 pacientes (29,8% de las solicitudes) recibieron SN, a pesar de presentar grado de nutrición normal o desnutrición leve de acuerdo al sistema CONUT. La mayor parte de dichas solicitudes (116; 74,4%) cumplían un único requisito para la dispensación de SN, y en el 93,9% de las mismas el criterio alegado por el médico solicitante era la disminución de la ingesta mayor del 50%. Conclusiones: Nuestro método de dispensación de SN detecta un mayor porcentaje de pacientes susceptibles de suplementación nutricional que el sistema CONUT. La principal ventaja de nuestro sistema es la valoración de la disminución de la ingesta, que es la principal indicación de SN en el medio hospitalario.